Mitoquidone
Mitoquidone (GR-30921) is is the first member of a group of pentacyclic pyrroloquinones. Mitoquidone shows good activity in a range of experimental solid tumour models. Mitoquidone can be used for the research of anti-cancer[1].
Product Specifications
CAS Number
91753-07-0
Product Name Alternative
GR-30921
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mitoquidone.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=CC=C12)C3=CN4CC5=C(C=CC=C5)CC4=C3C2=O
Molecular Formula
C20H13NO2
Molecular Weight
299.32
References & Citations
[1]P A Speth, et al. Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemother Pharmacol. 1988;21 (4) :343-6. |[2]Speth PA, et al. Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemother Pharmacol. 1988;21 (4) :343-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb982132 100 µL
Phospho-Wee1 (Ser53) Rabbit Polyclonal Antibody (Cy3)
Sign In for Pricing
View Details 